Cardiac Findings and Events Observed in an Open-Label Clinical Trial of Tafamidis in Patients with non-Val30Met and non-Val122Ile Hereditary Transthyretin Amyloidosis
Crossref DOI link: https://doi.org/10.1007/s12265-015-9613-9
Published Online: 2015-03-06
Published Print: 2015-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Damy, Thibaud
Judge, Daniel P.
Kristen, Arnt V.
Berthet, Karine
Li, Huihua
Aarts, Janske
Text and Data Mining valid from 2015-03-01
Version of Record valid from 2015-03-06
Article History
Received: 5 November 2014
Accepted: 3 February 2015
First Online: 6 March 2015